Categories
Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 14-05-2026: Board Meeting
14-05-2026 · 05:15 pm
Venmax Drugs & Pharma's Board has approved Q4 & FY26 audited financial results. Revenue hit ₹3.94 Cr for Q4 and ₹8.02 Cr for the full year. Profit for Q4 was ₹0.11 Cr and ₹0.25 Cr for FY26. The company also converted 63.44 lakh warrants to equity during the year.
No comments yet. Be the first to comment!